Welcome to CSNpharm! For Research Use Only!
Home Promotion +1-708-781-1677 sales@csnpharm.com    

NMDAR

NMDAR

Cat. No. Product Name CAS No. Information
CSN21328 UK-240455 178908-09-3 UK-240455 is a potent and selective N-methyl D-aspartate NMDA glycine site antagonist
CSN24287 Traxoprodil mesylate   189894-57-3 Traxoprodil a selective antagonist of the NR2B subunit of the NMDA receptor.
CSN12978 Traxoprodil 134234-12-1 Traxoprodil a selective antagonist of the NR2B subunit of the NMDA receptor
CSN21414 Transcrocetin Meglumine Salt N/A Transcrocetin meglumine salt extracted from saffron Crocus sativus L acts as an NMDA receptor antagonist with high affinity
CSN11907 SDZ 220-581 174575-17-8 SDZ 220-581 is a potent competitive antagonist at the NMDA glutamate receptor subtype pKi 77
CSN18033 SDZ 220-581 HCl 179411-93-9 SDZ 220-581 HCl is a potent, competitive antagonist at the NMDA glutamate receptor subtype (pKi= 7.7).
CSN18034 SDZ 220-581 Ammonium 179411-94-0 SDZ 220-581 ammonium is a potent competitive antagonist at the NMDA glutamate receptor subtype pKi 77
CSN15699 Sarcosine   107-97-1 Sarcosine is an NMDAR co-agonist at the glycine binding site. It is an intermediate and byproduct in glycine synthesis and degradation.
CSN17681 Ro 25-6981 Maleate 1312991-76-6 Ro 25-6981 maleate is a potent and selective activity-dependent blocker of NMDA receptors containing the NR2B subunit
CSN17353 Ro 25-6981 169274-78-6 Ro 25-6981 is a potent and selective activity-dependent blocker of NMDA receptors containing the NR2B subunit
CSN17520 Rapastinel 117928-94-6 Rapastinel is a putative NMDAR functional glycine-site partial agonist
CSN23784 Radiprodil 496054-87-6 Radiprodil is a selective antagonist of NMDA NR2B that used in treatment of neuropathic pain.
CSN23523 Quinolinic acid 89-00-9 Quinolinic acid is both a selective agonist at NMDA receptors and also a precursor for the formation of NAD
CSN16857 QNZ46   1237744-13-6 QNZ46 is a noncompetitive and voltage-independent GluN2CGluN2D-selective NMDA antagonist with IC50 values of 3 6 229 M for GluN2D GluN2C GluN2A respectively
CSN11780 Procyclidine HCl 1508-76-5 Procyclidine HCl is an potent anti-cholinergic agent, and is also known to have NMDA antagonist properties.
CSN17346 PEAQX 459836-30-7 PEAQX is a potent and orally active NMDA antagonist with a 15-fold preference for human NMDA receptors with the 1A2A IC50270 nM rather than 1A2B29600 nM
CSN19272 PEAQX Tetrasodium Hydrate N/A PEAQX is a potent and orally active NMDA antagonist with a 15-fold preference for human NMDA receptors with the 1A2A IC50270 nM rather than 1A2B29600 nM
CSN11619 Orphenadrine HCl 341-69-5 Orphenadrine HCl is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist with Ki of 6.0 ±0.7 μM.
CSN11618 Orphenadrine Citrate   4682-36-4 Orphenadrine Citrate is both an uncompetitive NMDA receptor antagonist IC50 value of 162 M and a mAChR antagonist with IC50 value of 037 M
CSN24186 NMDAR antagonist 1 2220162-06-9 NMDAR antagonist 1 is a NR2B-selective NMDAR antagonist.
CSN17347 NMDA-IN-1 700878-19-9 NMDA-IN-1 is a potent and NR2B-selective NMDA antagonist with Ki of 085 nM Its NR2B Ca2 influx IC50 is 97 nM without activities on NR2A NR2C NR2D hERG-channel and 1-adrenergic receptor
CSN13790 NMDA   6384-92-5 NMDA is an amino acid derived specific agonist at the NMDA receptor
CSN11379 Mephenesin   59-47-2 Mephenesin is a centrally acting muscle relaxant which may work as an NMDA receptor antagonist.
CSN11501 Memantine 19982-08-2 Memantine is the first in a class of Alzheimers disease medications acting on the glutamatergic system by blocking NMDA receptors
CSN13695 MDL-29951 130798-51-5 MDL-29951 is a glycine antagonist of NMDA receptor activation Ki014 mM 3Hglycine binding in vitro and in vivo
CSN13916 MDL 105519 161230-88-2 MDL 105519 is a potent and selective inhibitor of 3Hglycine binding to the NMDA receptor with Kd of 389 nM
CSN20030 Lanicemine 153322-05-5 Lanicemine is a low-trapping NMDA receptor antagonist Lanicemine is used the management of severe and treatment-resistant depression Lanicemine was originally developed as a neuroprotective agent but was redeveloped as an antidepressant
CSN17128 L-701,324 142326-59-8 L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor
CSN21303 Kynurenic Acid Sodium 2439-02-3 Kynurenic acid, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, 7 nicotinic acetylcholine receptor. Kynurenic acid is also a selective ligand of the GPR35 receptor.
CSN11186 Ifenprodil Tartrate   23210-58-4 Ifenprodil Tartrate is a high affinity and atypical noncompetitive NMDA receptor antagonist with IC50 of 03 M
CSN21125 Ibotenic Acid 2552-55-8 Ibotenic acid has agonist activity at both the N-methyl-D-aspartate NMDA and trans-ACPD or metabolotropic quisqualate Qm receptor sites
CSN22199 GNE 5729 2026635-66-3 GNE 5729 is a brain permeable positive allosteric modulator of NMDAR with an EC50 of 37 nM for GluN2A 47 and 95 M for GluN2C and GluN2D respectively
CSN22417 GNE 0723 1883518-31-7 GNE 0723 is a brain permeable positive allosteric modulator of NMDAR with an EC50 of 21 nM for GluN2A 74 and 62 M for GluN2C and GluN2D respectively
CSN10988 Felbamate 25451-15-4 Felbamate is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate NMDA
CSN17519 Felbamate Hydrate 1177501-39-1 Felbamate is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate NMDA
CSN10256 Eliprodil 119431-25-3 Eliprodil can antogonize GluN2B-selective NMDA in a non-competitive manner with IC50 value of 1 M It is also a 1 ligand with Ki value of 0013 M
CSN21590 D-AP5 79055-68-8 D-AP5 is an antagonist of NMDA receptor (N-methyl-D-aspartate receptor).
CSN18296 CIQ 486427-17-2 CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit
CSN19842 CGP 37849 127910-31-0 CGP 37849 is a potent selective and competitive NMDA receptor antagonist Ki 35 nM
CSN10502 Budipine 57982-78-2 Budipine is an uncompetitive NMDAR antagonist used as an antiparkinson agent
CSN22349 Apimostinel 1421866-48-9 Apimostinel is an oral NMDA receptor partial agonist.
CSN22086 7-Chlorokynurenic Acid Sodium Salt 1263094-00-3 7-Chlorokynurenic acid sodium salt is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex and also a potent inhibitor of the reuptake of glutamate into synaptic vesicles with Ki of 0.59 μM.
CSN24923 6-Methoxy-2-naphthoic acid 2471-70-7 6-Methoxy-2-naphthoic acid is an modulator of NMDAR.
CSN17580 (-)-MK 801 Maleate 121917-57-5 --MK 801 maleate is the enantiomer of -MK-801 which is a highly potent and selective non-competitive NMDA glutamate receptor antagonist
CSN23429 L-Glutamic Acid   56-86-0 (S)-Glutamic acid acts as an excitatory neurotransmitter in the central nervous system.
CSN13883 (+)-MK 801 Maleate 77086-22-7 ()-MK 801 Maleate is a highly potent, selective and non-competitive NMDA receptor antagonist with Ki of 30.5 nM.
CSN25441 (-)-Aspartic acid 1783-96-6
CSN25440 ACBC 22264-50-2
<< PREV 1 2 NEXT >>